Navigation Links
Lilly Provides Update on Next Steps for Solanezumab
Date:12/12/2012

INDIANAPOLIS, Dec. 12, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today provided an update on the next steps planned for solanezumab, its Phase 3 monoclonal antibody being studied as a potential therapy for patients with mild Alzheimer's disease. Following discussions with regulators in the U.S., Europe and Canada, Lilly plans to conduct an additional Phase 3 study of solanezumab in patients with mild Alzheimer's disease. Additional details, including study design and length, are still being determined. Lilly expects to initiate this study no later than Q3 2013.

Based on recent meetings with the U.S. Food and Drug Administration (FDA), Lilly does not intend to submit a Biologics License Application (BLA) at this time in the U.S. based solely on the existing analyses of data from the EXPEDITION studies. Lilly will continue to analyze and discuss the data from the two, Phase 3, double-blind, placebo-controlled solanezumab EXPEDITION studies with regulators globally to determine the regulatory paths forward in different regions. It is possible that different courses of action could be taken in different jurisdictions.

Independent analyses of the Phase 3 solanezumab EXPEDITION data were conducted by the Alzheimer's Disease Cooperative Study (ADCS), an academic research consortium, and presented at the annual meeting of the American Neurological Association (ANA) on Oct. 8, 2012, and at the Clinical Trial on Alzheimer's Disease (CTAD) meeting on Oct. 29, 2012.

"Based on both the independent analyses by the ADCS, as well as our own," said Eric Siemers, senior medical director of Lilly's Alzheimer's disease team, "we believe the results demonstrating a slowing of cognitive decline in patients with mild Alzheimer's disease treated with solanezumab are the first data from Phase 3 clinical trials that support the amyloid hypothesis."

"We remain en
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lilly to Expand Indianapolis Insulin Manufacturing Operations
2. Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
3. Lilly Celebrates 18th Consecutive Year as One of Working Mothers 100 Best Companies
4. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
5. Lilly Announces Results From Lung Cancer Study
6. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
7. Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results
8. U.S. Court of Appeals Upholds Validity of Lillys Alimta Compound Patent
9. Lilly Revises 2012 Reported Guidance to Reflect Income from Early Payment of Amylin Obligations
10. Lilly Announces Study Results Regarding Postmenopausal Women with Back Pain Caused by Vertebral Fractures
11. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- SAM ... (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that ... recall to address a potential issue with a ... for the Axilla application of the SAM Junctional ...
(Date:8/29/2014)... , Aug. 29, 2014  A Boston ... multinational study on stent removability and preliminary long ... been published in the August issue of the ... study 1 is being conducted in 11 ... fully covered self-expanding metal stents (FCSEMS) after extended ...
(Date:8/29/2014)... 29, 2014 Medina Medical announced today that ... of the Board of Directors on August 18, 2014. ... and commercialization experience, including over a decade of direct ... as a Partner of the medical device incubator The ... two Foundry start-ups. Mr. Engelson previously served as the ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... , ARDEE, Ireland, Dec. 11 As ... disclosed, its acquisition of the global branded prescription pharmaceuticals ... October 30, 2009 (the "PGP Acquisition"), constituted a change ... (the "Marketing Agreement") between a P&G subsidiary acquired by ...
... , BATESVILLE, Ind., Dec. 11 ... Hill-Rom,s Advanta(TM) 2 Bed for use in medical-surgical areas of hospitals and ... safety features and the flexibility to use a variety of care surfaces ... to our customers. It combines the best features of Hill-Rom,s long-time leader, ...
Cached Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4
(Date:8/30/2014)... UWDress.com, a distinguished wedding dress supplier, has gained a great ... outfits. Recently, the company has unveiled its beautiful collection of ... offer, all these brand new products are provided with big ... excited to unveil the new and trendy bridesmaid outfits and ... available at low prices now. The purpose of our company ...
(Date:8/30/2014)... Recently, iFitDress.com, one of the most ... of classy bridesmaid dresses . For additional information, ... percent off to 62 percent off) for all people ... , True enough, iFitDress.com is an industry leader ... The company persists in making trendy products that can ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The Truth about ... body that will reveal to users some shocking foods that ... great results in modeling looks, as well as some motivation ... method says that there is one unique trick that can ... indicates that despite what many people might think, cardio exercise ...
(Date:8/30/2014)... 2014 Fast hosting is a ... has recently compared many professional web hosting suppliers ... and Arvixe are the suppliers of fastest web ... find a good fast hosting supplier. Actually, these ... uptime, server speed and customer support. People can ...
(Date:8/30/2014)... 2014 According to Bloomberg , ... requires Takeda Pharmaceutical Co. and Eli Lilly & Co. ... that the drugmakers concealed information about a risk of ... case, Allen v. Takeda Pharmaceuticals North America Inc. (12-cv-00064), ... of Louisiana (Lafayette).* , According to Bloomberg, Takeda and ...
Breaking Medicine News(10 mins):Health News:UWDress.com’s Beautiful Collection Of “Flowy Bridesmaid Dresses” Released 2Health News:Classy Bridesmaid Dresses Announced By Loved Online Supplier iFitDress.com 2Health News:Truth about Six Pack Abs Review Reveals Unique Method to Eliminate Stubborn Stomach Fat 2Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2
... pregnancy loss are often concerned that toxins within ... Questions posed by these couples to their health ... accurate information regarding the reproductive impact of potential ... available. ,Heavy metals such as lead ...
... company, is racing giant rivals to bring a pill ... set a new standard in arthritis treatment. Scios' ambitions ... little more than $1 billion. That's because the first ... injectable drugs could gain the lion's share of a ...
... have found that a diet high in cholesterol and animal ... cancer of the stomach and esophagus that has been increasing ... dietary fiber, dietary beta-carotene, folic acid, vitamin C and vitamin ... cancers. ,The rate of a specific type of ...
... is a disorder of the eye where cells in the ... over 60 years of age.A new study states that eating ... ,Researchers from the department of Clinical Nutrition looked at ... information about their diet, and any vitamin supplements they were ...
... ready-to-eat meals could lead to the resurgence of botulism ... have made botulism a rare problem in modern society. ... ready-to-eat foods// that are only refrigerated before sold could ... cases involve mistakes in home canning or smoking of ...
... shows there is some truth in the 'use it or ... It is long been believed that mental stimulation can protect ... Disease Centre in the US now reveal new evidence for ... Study, involving the cognitive health of older Catholic nuns, priests ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: